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Abstract
Background: Schistosoma mansoni and malaria infections are often endemic in the same communities in sub-Saharan Africa, and
both have pathological effects on the liver and the spleen. Hepatosplenomegaly associated with S. mansoni is exacerbated in
children with relatively high exposure to malaria. Treatment with praziquantel reduces the degree of hepatosplenomegaly, but
the condition does not completely resolve in some cases. The present analysis focused on the possibility that exposure to
malaria infection may have limited the resolution of hepatosplenomegaly in a cohort of Kenyan schoolchildren.
Methods: Ninety-six children aged 6–16, from one community in Makueni district, Kenya, were treated with praziquantel. At
baseline, all children had hepatomegaly and most had splenomegaly. The source of S. mansoni infection, a river, was molluscicided
regularly over the following three years to limit S. mansoni re-infection, whereas malaria exposure was uninterrupted. Hepatic
and splenic enlargement was assessed annually outside the malaria transmission season.
Results: Children living in an area of relatively high exposure to both infections presented with the largest spleens before
treatment and at each follow-up. Spleens of firm consistency were associated with proximity to the river. The regression of
hepatomegaly was also affected by location, being minimal in an area with relatively low S. mansoni exposure but high exposure
to malaria, and maximal in an area with relatively low exposure to both infections.
Conclusions: The outcome of treating cases of hepatosplenomegaly with praziquantel in this cohort of Kenyan children
depended strongly on their level of exposure to malaria infection. Furthermore, a residual burden of hepatosplenic morbidity
was observed, which was possibly attributable to the level of exposure to malaria. The results suggest that exposure to malaria
infection may be a significant factor affecting the outcome of praziquantel treatment to reduce the level of hepatosplenic
morbidity.
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Hepatosplenomegaly is a widespread but neglected condi-
tion affecting many communities in sub-Saharan Africa
where both Schistosoma mansoni and malaria infections are
endemic. Severely enlarged and hard organs may be an
indicator of increased portal pressure, as well as pointing
to an increased risk of portal hypertension and its seque-
lae, including oesophageal varices and haematemesis [1].
Historically, hepatomegaly in sub-Saharan Africa has
been associated with S. mansoni infection, and on a global
scale up to 8.5 million individuals may be affected [2],
with the prevalence of organomegaly generally highest in
children [3]. Enlargement of spleens has often been asso-
ciated with the level of malaria transmission [4,5]. One
prevailing suggestion has been that hepatosplenomegaly
amongst younger children is attributable to malaria infec-
tion, whereas older children have acquired some level of
immunity to malaria and hence if they do have hepat-
osplenomegaly it is likely to be attributable to schisto-
somiasis [6]. However, chronic splenomegaly associated
with portal hypertension has been reported in Kenyan
hospitals amongst residents from areas where both S.
mansoni and malaria infections are endemic [7,8], and it
has long been suggested that the presence of both infec-
tions may confound attempts to quantify the impact of
either one [9,10]. Recently, it was observed that IgG3 anti-
body responses to P. falciparum schizont antigen (Pfs Ag)
were higher in Kenyan children with S. mansoni infection
and hepatosplenomegaly compared with children with
infection but no hepatosplenomegaly [11], further impli-
cating exposure to malaria in childhood as a risk factor for
severe hepatosplenic morbidity.
Given that malaria and schistosome infections are often
endemic in the same communities, and are both targets of
large-scale but independent, intervention programmes, it
is important to understand how continued exposure to
one parasite may affect the outcome of intervention
against the other. The current longitudinal study evalu-
ated praziquantel treatment on the regression of hepat-
osplenomegaly amongst children living in an area with
endemic S. mansoni infection and seasonal malaria infec-
tion [12,13]. Before treatment, there was a strong correla-
tion between S. mansoni egg count and the degree of both
hepatomegaly and splenomegaly [12]. However, spatial
analysis then revealed heterogeneity in exposure to both
infections, and in particular there was an exacerbation of
splenomegaly amongst children living in an area of rela-
tively high exposure to both malaria and S. mansoni infec-
tions [14]. The prevalence of hepatomegaly and
splenomegaly decreased slowly during the three-year fol-
low-up period, but had not completely abated by the end
of the study [13]. Here, we report that the level of expo-
sure to malaria infection was likely to have been an
important factor in limiting the resolution of hepat-
osplenomegaly in these children.
Methods
Study area
Mbeetwani is situated in the district of Makueni, half way
between Nairobi and Mombasa and approximately 10 km
east of the main highway. The ethnic background of the
population is predominantly Akamba. During the dry sea-
sons, the river Kambu is the main source of water. Run-
ning from west to east, the river lies to the north of the
community (Figure 1). Surface water is present at the
western end during the dry season, whereas the eastern
end is dry and water is retrieved by digging wells into the
riverbed. River water is drawn for drinking, cooking and
other domestic purposes. Washing of clothes and bathing
takes place at numerous sites, and animals are taken to the
river to drink.
Clinical examination
The cohort and examination procedure are described in
detail elsewhere [12]. Briefly, 96 children aged between 6
and 16 were selected for ultrasound detectable hepatome-
galy after a community survey. They were examined
before treatment with praziquantel at 40 mg/kg, and then
examined again in the same month in the following three
years. Treatment was given again two years into the study.
All surveys took place in October of each year, towards the
end of the dry season. A total of 67 children attended all
examinations, whereas 71 children attended at least the
baseline and third year follow-up surveys. Clinical exami-
nation consisted of liver and spleen palpation whilst chil-
dren were in a supine position. Un-palpable spleens and
livers were recorded as such, otherwise extensions in cm
below the rib cage along the mid-clavicular line (MCL)
and mid sternal line (MSL) were measured for the liver,
and extension below the rib cage along the mid-clavicular
and mid axillary lines (MAL) was recorded for the spleen.
The firmness of each palpable organ was recorded as
either soft, firm, or hard, as described previously [12]. An
accompanying ultrasound examination was conducted
according to World Health Organisation guidelines [15]
to test for the presence of periportal fibrosis. Both the cli-
nicians and the ultrasonographers were blinded as to the
location of children's domiciles and previous examina-
tion results, and the same team performed the examina-
tions throughout the study period.
Mapping
Details of the mapping procedure are given elsewhere
[14]. Briefly, the longitude and latitude of each house
were recorded using a Magellan GPS 315 receiver. The
course of the river Kambu was determined by taking read-
ings approximately every 100 metres along a ten kilome-
tre stretch that extended beyond the borders of the studyPage 2 of 10
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BMC Medicine 2004, 2:36 http://www.biomedcentral.com/1741-7015/2/36Map of the study area showing the course of the River Kambu, positions of cohort members households and the four sectors corresponding to area  of d fferent exposure to S. mansoni and malaria infectionsFigure 1
Map of the study area showing the course of the River Kambu, positions of cohort members households and the four sectors 
corresponding to areas of different exposure to S. mansoni and malaria infections. The accompanying table contains the median 
and 25–75%ile ranges for egg counts (e.p.g.) before treatment and anti-Pfs IgG3 OD responses for each sector.
IgG3 OD @ 490 nmS. mansoni egg counts
0.044       0.053 0.0970.0              3.3 63.3D
0.025     0.074 0.135 39.2         140.8 312.5C
0.131       0.162 0.22413.3          43.3 133.3B
0.089       0.145 0.19975.8         141.7 387.5A
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BMC Medicine 2004, 2:36 http://www.biomedcentral.com/1741-7015/2/36area. The approximately rectangular study area was
divided into 4 sectors with similar numbers of houses by
bisecting the north-south and east-west transects at 4 km
east of the western boundary and 1 km south of the river.
Assays
Since the surveys were undertaken during the dry season,
parasitaemia was not expected to provide a good enough
estimate of exposure. Therefore, anti-Pfs IgG3 responses
were used as a proxy measure of recent exposure [16],
measured by ELISA as described previously [17].
Parasitology
For the quantification of S. mansoni eggs, each child pro-
vided 3 stool samples before the baseline survey in Octo-
ber 1999. Two 50 mg Kato slides were prepared from each
stool sample using the Kato-Katz procedure [18]. All
slides were prepared and examined by the same team. Fin-
ger-prick blood samples were taken on the same day that
clinical and ultrasound examinations were performed, for
detection of malaria parasitaemia.
Mollusciciding
Regular mollusciciding of the river Kambu was under-
taken with Bayluscide ® (Bayer CropScience AG, Alfred-
Nobel-Str 50, D40789 Monheim am Rhein, Germany).
Area-wide application and focal spraying using backpacks
was undertaken twice yearly to coincide with periods
when snail populations were reduced due to environmen-
tal conditions. Snail sampling activities at 9 sites on a
monthly basis were undertaken to confirm that snail
numbers were kept at very low levels (HC Kariuki, unpub-
lished observations).
Treatment and ethical considerations
The objectives of the study were carefully explained to the
local community including the parents and teachers
before the start of any activities. Informed assent was
obtained from the parents or guardians of the children.
After the clinical and ultrasound examination in October
1999, all children were treated with a single dose of prazi-
quantel (Distocide®, Shin Poon Pharmaceuticals, Seoul,
Republic of Korea), at 40 mg/kg body weight. The chil-
dren were again treated in 2001 and 2002 under the same
regimen. No other source of treatment was available
locally during this period. Tablets were administered
together with a piece of bread and a soft drink in order to
minimise gastrointestinal side effects. The study was
approved by the Kenya Medical Research Institute Ethical
Review Committee.
Analysis
Baseline data for each parameter were compared with 3
year follow up data amongst 71 children who attended
the first and last surveys to estimate the number of chil-
dren within each sector who presented with a lower
degree of organomegaly at the end of the study. Repeated-
measures ANOVA of each organ enlargement parameter
was also undertaken for the 67 children who attended all
surveys, with age, sex and sector of residence as fixed fac-
tors. Since ANOVA does not indicate the direction of any
change, a post-hoc analysis was undertaken within each
sector to determine whether there was an overall increase
or decrease in the extent of organomegaly. This was
achieved by comparing baseline enlargement and enlarge-
ment after 3 years follow up for each parameter, using the
Wilcoxon Signed Ranks test. All analyses were conducted
in SPSS v11 (SPSS inc, 2001, Chicago).
Results
Geographical distribution of exposure
Figure 1 illustrates the geographical distribution of houses
within the study area, as well as the course of the river
Kambu. A total of 70 houses were geo-referenced. Also
given are the median and 25–75%ile range of egg counts
and anti-Pfs IgG3 responses within each sector before the
intervention. Details of the analysis of S. mansoni egg
counts and IgG3 responses within each sector are given
elsewhere [14]. Briefly, there was a significant clustering of
high egg counts in children living at the western end of the
study area (Sector A and Sector C). Significant clustering
of the highest anti-Pfs IgG3 responses was observed
amongst children living in the two northern sectors (Sec-
tor A and Sector B). Thus, sector A was an area of relatively
high exposure to both infections, sector B was an area of
relatively high exposure to malaria only, sector C was an
area of relatively high exposure to S. mansoni only, and
sector D was an area of low exposure to both infections.
Temporal changes in organ consistency by sector
Significant variation in the prevalence of hard spleens
over time was observed within each sector (Table 1),
attributable to an overall decline in the number of chil-
dren with hard and enlarged spleens (Figure 2a). The prev-
alence of hardened spleens was highest at all time points
in the sector with relatively high anti-Pfs IgG3 responses
and high egg counts (Sector A). By two years post-treat-
ment, no child resident more than one kilometre from the
river presented with a hard spleen.
The prevalence of firm livers in all sectors varied over
time, except in sector B (Table 1). In all other sectors there
was a decrease in the prevalence of firm livers over the
course of the follow-up period (Figure 2b). At the end of
the study, the lowest prevalence of firm livers was
observed in children from sector D.
Temporal changes in organomegaly by sector
Significant variation in the degree of MAL splenomegaly
was observed in each sector over the three-year follow-upPage 4 of 10
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degree of MAL splenomegaly within each sector, and this
was confirmed by post-hoc Wilcoxon Rank analysis (Table
2). The rate of regression was affected independently nei-
ther by sector, age nor sex, and children from sector A pre-
sented with the largest spleens at each time point. At the
third year post treatment follow-up, the fraction of each
group presenting with no MAL splenomegaly in each sec-
tor was 10/24 (Sector A), 6/14 (Sector B), 13/15 (Sector
C), and 16/20 (Sector D). MCL splenomegaly also varied
significantly over time (Figure 3b, F = 14.1, p < 0.001), but
the extent of variation was affected by sector (F = 2.191, p
= 0.024). Post-hoc Wilcoxon rank analysis revealed that
there was a significant decrease in the extent of MCL
splenomegaly only in sector D (Table 2).
MSL liver enlargement varied significantly over time (F =
3.78, p = 0.012), with the variation being affected by sec-
tor (F = 2.57, p = 0.008). There was no consistent decline
in MSL hepatomegaly over time within any one sector
(Figure 3c). Although a fraction of the children in each
sector presented with reduced hepatomegaly at the third
year follow-up, Wilcoxon Rank analysis of the direction of
change within each sector confirmed that an overall sig-
nificant decrease in the extent of MSL hepatomegaly
between the baseline survey and the third year follow-up
occurred only amongst children from sector D (Table 2).
Children from sector B presented with the least improve-
ment in MSL hepatomegaly, with 10/12 exhibiting no
change or an increase in this parameter when baseline
data were compared with data from the third year follow-
up. MCL hepatomegaly values could not be used in the
repeated measures analysis due to a lack of normal varia-
tion in the data. Wilcoxon rank analysis within sectors
revealed no significant change in this measurement
between baseline and the third year follow-up in any sec-
tor (Table 2).
Ultrasound results
There was no evidence of periportal fibrosis in any of the
children at any time point.
Discussion
Many clinical surveys of sub-Saharan communities have
reported that organomegaly of the spleen or liver is a very
common condition, but attribution to a specific aetiology
has always been problematic. Distinguishing the contri-
bution of malaria from that of schistosome infections is
particularly complex since they are often endemic in the
same communities. However, it is well established that
exposure to both S. mansoni and malaria varies over small
areas [19-21], and the potential therefore exists to com-
pare morbidity in areas of overlapping exposure with
areas where infections of one species are more prevalent.
Here, we have exploited observations concerning micro-
geographical variation in the distribution of each infec-
tion to demonstrate how the benefits of treatment with
praziquantel on hepatosplenomegaly may be affected by
local heterogeneity in malaria exposure. Our results fur-
ther implicate both parasites as aetiological agents of
chronic hepatosplenomegaly including firmness of the
organs in school-aged children, and have strong implica-
tions not only for estimating the burden of S. mansoni and
malaria, but also for estimating the outcome of
interventions.
The generation of these results was facilitated by several
important features of the study design. The intermittent
mollusciciding of the river Kambu was particularly impor-
tant, since it reduced the potential for morbidity to
rebound as a result of re-infection, as has been seen else-
where in studies of both S. mansoni and S. haematobium
[22]. The timing of the follow-up surveys outside the
malaria transmission season was another important com-
ponent, since it allowed an assessment of the clinical situ-
ation without the confounding effects of transient
morbidity associated with acute malaria. Without these
particular features, it is unlikely that we could have come
to any conclusions about the effects of chronic exposure
to malaria infection on the regression of hepatosplenom-
egaly. Another important component of the study was the
mapping of both house co-ordinates and the local river.
By doing so, we were able to identify spatial clustering of
Table 1: Results of testing for variation in the prevalence of hard spleens and firm livers over time within each sector. Sector is described 
in the legend to table 1. Q – Cochrans Q statistic, N – number of individuals with relevant data from all time points, p – level of 
significance.
Hard spleens Firm Livers
Sector N Q p Q p
A 21 14.0 0.003 13.2 0.004
B 12 9.0 0.029 5.0 0.172
C 15 8.3 0.041 7.8 0.049
D 19 12 0.007 10.7 0.013Page 5 of 10
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BMC Medicine 2004, 2:36 http://www.biomedcentral.com/1741-7015/2/36Bar charts depicting temporal (by year) and spatial (by sector) variation in the prevalence of hard spleens (Figure 2a) and firm livers (Figure 2b)Figure 2
Bar charts depicting temporal (by year) and spatial (by sector) variation in the prevalence of hard spleens (Figure 2a) and firm 
livers (Figure 2b). Estimates are from the baseline survey and surveys conducted up to three years after first treatment (Rx) 
with praziquantel.
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BMC Medicine 2004, 2:36 http://www.biomedcentral.com/1741-7015/2/36Box and whisker plots depicting temporal (by year) and spatial (by sector) variation in spleen enlargement along the mid axil-lary li e (Figur  3a) and the mid clavicular line (Figure 3b), s well a  live  enlargement along the mid st rnal li e (Figure 3c)Figure 3
Box and whisker plots depicting temporal (by year) and spatial (by sector) variation in spleen enlargement along the mid axil-
lary line (Figure 3a) and the mid clavicular line (Figure 3b), as well as liver enlargement along the mid sternal line (Figure 3c). 
The horizontal line within each box represents the median; the lower and upper bounds of the box correspond to the 25- and 
75%iles; the whiskers correspond to the range of non-outlying data. Measurements are from the baseline survey and surveys 
conducted up to three years after first treatment (Rx) with praziquantel.
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the study area. Such clustering is likely related to variation
in the amount of surface water along the river, and hence
variation in transmission potential due to the strong rela-
tionship between snail abundance and water level
observed during long term studies of transmission in this
area [23]. The clustering of anti-Pfs IgG3 responses to sch-
izont antigen along a tract parallel to the course of the
river suggests a sharp decrease in transmission further
from the river [14].
Although we observed several significant changes follow-
ing praziquantel treatment of the cohort, it is important to
note that this was a retrospective analysis, which carries a
few limitations. The observations made in this study were
based on a small, case-only cohort, and therefore do not
represent the outcome of an intervention programme
involving mass treatment of a population. As this was a
retrospective analysis, no control was possible concerning
treatment for malaria during the follow-up period. The
population had access to antimalarial drugs at local
shops, but so far as we are aware there was no systematic
intervention against malaria infection during the follow-
up period. The results therefore encompass the effects of
background treatment for, as well as exposure to, malaria
infections.
Reliability of the clinical measurements is an important
factor, especially given the size of the cohort. We have
assessed this procedure elsewhere and it has been found
to be satisfactory (unpublished observations). The
involvement of three or four clinicians at each examina-
tion also reduced the degree of imprecision in the orga-
nomegaly measurements, and previous analysis has
demonstrated that interpretable changes in the measure-
ments occurred within this cohort [13].
The major result from this analysis is that the outcome of
treatment with praziquantel, combined with very limited
S. mansoni re-infection, depended strongly on where
members of the cohort were resident. Previously, we dem-
onstrated that children within the same cohort that had
relatively high-level exposure to both S. mansoni and
malaria presented with significantly larger spleens before
treatment than children highly exposed to either parasite
alone [14]. This contrasted with an observation on
splenomegaly in school children exposed to malaria only
in Ghana, where splenomegaly was observed to decline
with distance from mosquito breeding sites [5]. Here, we
report that children with relatively large spleens at
baseline and living in the area with high levels of exposure
to malaria still had the largest spleens 3 years after treat-
ment, despite an overall reduction in their organomegaly.
Hardness of enlarged spleens at baseline was most com-
monly observed amongst children living close to the river,
irrespective of their level of pre-treatment intensity of S.
mansoni infection [14]. In the absence of follow-up data,
the inference may have been that the hard consistency of
enlarged spleens was primarily attributable to chronic
malaria exposure. However, during the follow-up period,
we observed a gradual and monotonic decrease in the
prevalence of hard spleens that suggests the removal of S.
mansoni infection was the trigger for the improvement
[13]. One possible explanation is that the hardening of
the spleens was due to a synergistic effect of co-infection.
Hyperplasia and congestion in the spleen associated with
relatively high levels of exposure to malaria may have
been sufficient to cause chronic enlargement of the
spleen. Hardening and further enlargement may then
have occurred as a secondary effect of congestion in the
liver attributable to schistosome infection, leading to
increased portal pressure and dilation of the splenic
vasculature.
Three years after treatment with praziquantel, and with
very limited re-infection by S. mansoni [12], the preva-
lence of palpable spleens had diminished considerably. At
Table 2: Improvement in hepatosplenomegaly stratified by level of exposure to malaria and S. mansoni. Sectors are identified by letter 
and are described in the text. Ni – number of children in each sector with improved organomegaly at the 3 year follow up; Nt – total 
number of children examined at the third year follow-up; Z-Wilcoxon Rank analysis Z score indicating whether or not there was a 
decrease in the degree of organ enlargement between baseline and the 3 year follow up. A negative Z value and a corresponding p value 
of <0.05 indicates a significant decrease in organ sizes within a given sector.
MAL splenomegaly MCL splenomegaly MSL hepatomegaly MCL hepatomegaly
Sector Ni/Nt Z p Ni/Nt Z p Ni/Nt Z p Ni/Nt Z p
A 21/23 -3.81 <0.001 15/23 -1.20 0.234 10/23 -1.54 0.125 7/23 -0.11 0.915
B 9/13 -2.58 0.010 5/13 -0.42 0.673 2/12 1.39 0.164 1/12 -1.54 0.123
C 9/15 -2.72 0.007 5/15 -1.13 0.260 8/15 -1.22 0.222 2/13 -128 0.201
D 18/20 -3.78 <0.001 9/20 -2.72 0.007 12/20 -2.80 0.005 4/20 0.00 1.000Page 8 of 10
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degree of splenomegaly were highest amongst children
living in the sector with highest egg counts before inter-
vention and highest anti-Pfs IgG3 responses. By removing
S. mansoni infection and limiting re-infection, we may
have abrogated any synergistic effects of co-infection on
the spleen, and thereby uncovered the residual burden of
chronic exposure to malaria. Importantly, the rate of
regression of MAL splenomegaly was not affected signifi-
cantly by location, which suggests that the effects of prazi-
quantel treatment on splenomegaly attributable to S.
mansoni infection are not dependent on the level of expo-
sure to either malaria or S. mansoni.
The effects of praziquantel treatment on hepatomegaly in
this cohort were more subtle. There was gradual decline in
the prevalence of hepatomegaly after praziquantel treat-
ment [13] indicating that the removal of S. mansoni infec-
tion was a critical factor for improvement. However, upon
analysing hepatomegaly data across sectors, it emerged
that children from the sector with relatively high anti-Pfs
IgG3 responses, but relatively low S. mansoni egg counts,
had the lowest rate of regression. A possible explanation
of this observation is that an aetiological agent other than
S. mansoni was responsible for the observed hepatomeg-
aly. A likely candidate is malaria infection. Enlargement of
the liver in acute malaria infection is temporary and
recedes rapidly after treatment [24]; however, studies of
young children in Gambia have shown that repeated
infection with malaria, perhaps when combined with
other unidentified factors, can lead to the development of
chronically enlarged livers [25,26]. Our observations sug-
gest that even if school-aged children are examined out-
side the malaria transmission season, they may still be
affected by hepatomegaly attributable to
malariainfection.
Children from the sector with relatively low exposure to
both infections experienced a significant decrease in liver
enlargement along the mid sternal line when baseline
data were compared with data from the third year follow-
up. It is possible that hepatomegaly in these children was
attributable to neither S. mansoni nor malaria infection.
Alternatively, because they were relatively lightly infected
with S. mansoni, and experienced relatively low exposure
to malaria infection, it is possible that they were more
likely to regress in terms of hepatomegaly within the fol-
low-up period.
Conclusions
In conclusion, our observations lend further support to
the hypothesis that severity of hepatosplenomegaly in
Kenyan school-aged children is related to their degree of
exposure to both S. mansoni and malaria infections. Spe-
cifically, although the degree of hepatomegaly or
splenomegaly may be correlated with S. mansoni infec-
tion, there is likely to be further exacerbation of the con-
dition if a child is concurrently exposed to malaria. We
have now observed that the apparent benefits of treating a
case of hepatosplenomegaly with praziquantel may be
reduced if a child lives in an area of relatively high expo-
sure. We have therefore confirmed the long-standing, but
untested, hypothesis that co-infections of S. mansoni and
malaria may obscure the clinical evaluation associated
with infection by either species. Our results also introduce
the necessity of considering the level of exposure to
malaria when evaluating the clinical outcome of praziqu-
antel treatment for S. mansoni infection.
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